Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Medical Equipment Industry Analysis

UpdatedDec 15, 2025
DataAggregated Company Financials
Companies54
  • 7D-0.9%
  • 3M-6.2%
  • 1Y-22.1%
  • YTD-17.0%

In the last week, the Medical Equipment industry is flat overall, with Implantica standing out by going down 10%. Unfortunately though, the industry is down 22% over the past 12 months. Earnings are forecast to grow by 25% annually.

Industry Valuation and Performance

Has the Swedish Medical Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 16 Dec 2025SEK 175.1bSEK 94.0bSEK 2.4b42.2x72x1.9x
Thu, 13 Nov 2025SEK 182.1bSEK 94.2bSEK 2.4b46.2x77.2x1.9x
Sat, 11 Oct 2025SEK 177.5bSEK 93.3bSEK 1.4b46.7x127.3x1.9x
Mon, 08 Sep 2025SEK 184.0bSEK 93.3bSEK 1.4b50x133.3x2x
Wed, 06 Aug 2025SEK 190.0bSEK 93.5bSEK 1.4b51.2x131.1x2x
Fri, 04 Jul 2025SEK 195.4bSEK 93.4bSEK 1.5b41.9x129.4x2.1x
Sun, 01 Jun 2025SEK 191.3bSEK 93.4bSEK 1.5b34.2x131.4x2x
Tue, 29 Apr 2025SEK 171.5bSEK 92.3bSEK 2.4b28.6x71.4x1.9x
Thu, 27 Mar 2025SEK 156.2bSEK 76.4bSEK 2.5b28.1x62.5x2x
Sat, 22 Feb 2025SEK 169.2bSEK 76.3bSEK 2.1b31.5x81.3x2.2x
Mon, 20 Jan 2025SEK 161.5bSEK 74.7bSEK 1.8b31x88.5x2.2x
Wed, 18 Dec 2024SEK 152.9bSEK 74.7bSEK 1.8b27.6x83.9x2x
Fri, 15 Nov 2024SEK 160.4bSEK 75.1bSEK 2.0b32.9x80.3x2.1x
Sun, 13 Oct 2024SEK 177.0bSEK 74.5bSEK 3.1b23.8x56.8x2.4x
Tue, 10 Sep 2024SEK 178.4bSEK 74.6bSEK 3.1b25.6x57.4x2.4x
Thu, 08 Aug 2024SEK 164.8bSEK 74.4bSEK 3.3b27.3x50.5x2.2x
Sat, 06 Jul 2024SEK 160.2bSEK 72.9bSEK 2.6b30x61x2.2x
Mon, 03 Jun 2024SEK 169.6bSEK 73.0bSEK 2.8b33.9x59.9x2.3x
Wed, 01 May 2024SEK 174.1bSEK 73.0bSEK 2.7b34.3x64.9x2.4x
Fri, 29 Mar 2024SEK 167.5bSEK 72.3bSEK 2.4b33.1x69x2.3x
Sun, 25 Feb 2024SEK 160.6bSEK 72.0bSEK 2.3b33.8x69.1x2.2x
Tue, 23 Jan 2024SEK 170.3bSEK 71.5bSEK 1.5b46.3x111.6x2.4x
Thu, 21 Dec 2023SEK 168.9bSEK 71.4bSEK 1.5b39.5x110.2x2.4x
Sat, 18 Nov 2023SEK 162.9bSEK 70.0bSEK 1.4b31.9x120.5x2.3x
Mon, 16 Oct 2023SEK 145.8bSEK 68.7bSEK 1.1b26.8x134.6x2.1x
Wed, 13 Sep 2023SEK 151.5bSEK 68.8bSEK 1.1b30.5x143.5x2.2x
Fri, 11 Aug 2023SEK 161.3bSEK 68.0bSEK 925.6m32.1x174.3x2.4x
Sun, 09 Jul 2023SEK 156.2bSEK 67.0bSEK 1.3b33.4x116.4x2.3x
Tue, 06 Jun 2023SEK 178.4bSEK 66.9bSEK 1.3b36.5x132.2x2.7x
Thu, 04 May 2023SEK 180.9bSEK 65.6bSEK 1.4b36.1x128.4x2.8x
Sat, 01 Apr 2023SEK 174.6bSEK 64.0bSEK 1.4b36.4x121.7x2.7x
Mon, 27 Feb 2023SEK 167.3bSEK 63.7bSEK 1.7b40x96.9x2.6x
Wed, 25 Jan 2023SEK 177.9bSEK 61.8bSEK 2.3b31x76.9x2.9x
Fri, 23 Dec 2022SEK 156.1bSEK 61.8bSEK 2.3b26.1x67.4x2.5x
Price to Earnings Ratio

67.4x


Total Market Cap: SEK 156.1bTotal Earnings: SEK 2.3bTotal Revenue: SEK 61.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Medical Equipment Industry Price to Earnings3Y Average 98.4x202320242025
Current Industry PE
  • Investors are pessimistic on the Swedish Medical Equipment industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 72.0x which is lower than its 3-year average PE of 98.4x.
  • The 3-year average PS ratio of 2.3x is higher than the industry's current PS ratio of 1.9x.
Past Earnings Growth
  • The earnings for companies in the Medical Equipment industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 15% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-0.022%
Healthcare-1.09%
Medical Equipment-0.93%
Medical Equipment0.36%
Medical Supplies-3.56%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry, which is trading close to its 3-year average PE ratio of 79.3x.
    • Analysts are expecting annual earnings growth of 18.9%, which is higher than its past year's earnings decline of 42.6% per year.
  • Investors are most pessimistic about the Medical Supplies industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average.
Forecasted Growth
  • Analysts are most optimistic on the Medical Supplies industry, expecting annual earnings growth of 37% over the next 5 years.
  • However this is lower than its past earnings growth rate of 65% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 19% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GETI B GetingeSEK 212.602.3%
+SEK 1.3b		22.1%PE28.2x
EKTA B ElektaSEK 56.303.1%
+SEK 649.5m		-9.8%PE73.7x
NANEXA NanexaSEK 3.3786.8%
+SEK 248.5m		29.6%PS16.8x
SEZI SenzimeSEK 5.279.6%
+SEK 72.3m		-7.5%PS9.2x
SUS Surgical Science SwedenSEK 33.603.1%
+SEK 51.0m		-78.5%PE24.6x

Latest News

QLINEA
SEK 21.57
Q-linea
7D
-10.5%
1Y
-97.9%

QLINEA: Expanded Sepsis Panel Approval Will Drive Strong Future Upside

Narrative Update on Q-linea The analyst price target for Q-linea was maintained at SEK 53.00, as analysts cite largely unchanged assumptions around long term revenue growth, profitability, and valuation multiples, with only immaterial model refinements to the discount rate and future earnings expectations. What's in the News Q-linea completed a SEK 312.4 million follow-on rights offering of ordinary shares, strengthening the balance sheet and funding growth initiatives (company filing).
SUS
SEK 33.60
Surgical Science Sweden
7D
3.1%
1Y
-78.5%

SUS: Future Returns Will Reflect Lost Partnership And Lower Profit Outlook

Analysts have cut their price target on Surgical Science Sweden sharply from SEK 120.00 to SEK 33.00, citing reduced expectations for revenue growth, profit margins, and future valuation multiples despite only a modest uptick in the assumed discount rate. What's in the News Intuitive cancels its memorandum of understanding to integrate Surgical Science's simulation software into all da Vinci 5 systems, leading the company to warn it will miss its 2026 financial targets due to an estimated SEK 60 million to SEK 90 million revenue shortfall in that year (Corporate Guidance: Lowered).
CARE
SEK 24.10
Careium
7D
-10.7%
1Y
-18.3%

Careium AB (Publ) (STO:CARE) Might Not Be As Mispriced As It Looks

Dec 12
Careium AB (Publ) (STO:CARE) Might Not Be As Mispriced As It Looks
NANEXA
SEK 3.37
Nanexa
7D
86.8%
1Y
29.6%

Is Nanexa (STO:NANEXA) Using Debt Sensibly?

Dec 12
Is Nanexa (STO:NANEXA) Using Debt Sensibly?
SEZI
SEK 5.27
Senzime
7D
9.6%
1Y
-7.5%
ADDV A
SEK 1.66
ADDvise Group
7D
-15.8%
1Y
-84.7%
EKTA B
SEK 56.30
Elekta
7D
3.1%
1Y
-9.8%
ASKER
SEK 88.20
Asker Healthcare Group
7D
-1.6%
1Y
n/a
VIMIAN
SEK 28.32
Vimian Group
7D
-5.5%
1Y
-30.8%

VIMIAN: Future Leadership Will Drive Cash Flow Execution Upside Despite Sector Downgrade

Analysts have trimmed their price target on Vimian Group by SEK 10 to SEK 27. This reflects slightly higher discount rate assumptions and more conservative long term valuation multiples for the sector.
XVIVO
SEK 174.50
Xvivo Perfusion
7D
-5.4%
1Y
-63.2%
IMP A SDB
SEK 48.00
Implantica
7D
-10.1%
1Y
30.4%
SEDANA
SEK 10.30
Sedana Medical
7D
4.6%
1Y
-38.2%
STIL
SEK 185.00
Stille
7D
-3.4%
1Y
1.4%

Stille AB's (STO:STIL) P/E Still Appears To Be Reasonable

Nov 24
Stille AB's (STO:STIL) P/E Still Appears To Be Reasonable
CMOTEC B
SEK 4.70
Scandinavian ChemoTech
7D
23.0%
1Y
226.4%
GETI B
SEK 212.60
Getinge
7D
2.3%
1Y
22.1%
PRLD
SEK 21.00
Prolight Diagnostics
7D
7.7%
1Y
51.1%